Search research articles
Contact Us
Filters
Showing results (61-70 of 66) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 66 results.
The Journal of Pharmacology and Experimental Therapeutics
|
July 21, 2012
Pharmacological properties and procognitive effects of ABT-288, a potent and selective histamine H3 receptor antagonist
Timothy A Esbenshade, Kaitlin E Browman, Thomas R Miller, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 22, 2008
Characterization of a cannabinoid CB2 receptor-selective agonist, A-836339 [2,2,3,3-tetramethyl-cyclopropanecarboxylic acid [3-(2-methoxy-ethyl)-4,5-dimethyl-3H-thiazol-(2Z)-ylidene]-amide], using in vitro pharmacological assays, in vivo pain models, and pharmacological magnetic resonance imaging
Betty B Yao, Gin Hsieh, Anthony V Daza, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 21, 2004
Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: II. Neurophysiological characterization and broad preclinical efficacy in cognition and schizophrenia of a potent and selective histamine H3 receptor antagonist
Gerard B Fox, Timothy A Esbenshade, Jia Bao Pan, et al.
Biochemical Pharmacology
|
March 21, 2007
Novel heterocyclic-substituted benzofuran histamine H3 receptor antagonists: in vitro properties, drug-likeness, and behavioral activity
Marlon Cowart, Gregory A Gfesser, Kaitlin E Browman, et al.
Epilepsia
|
September 9, 2005
Preclinical profiling and safety studies of ABT-769: a compound with potential for broad-spectrum antiepileptic activity
William J Giardina, Michael J Dart, Richard R Harris, et al.
CNS Neuroscience & Therapeutics
|
May 17, 2008
Preclinical characterization of A-582941: a novel alpha7 neuronal nicotinic receptor agonist with broad spectrum cognition-enhancing properties
Karin R Tietje, David J Anderson, R Scott Bitner, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 66) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 66 results.
The Journal of Pharmacology and Experimental Therapeutics
|
July 21, 2012
Pharmacological properties and procognitive effects of ABT-288, a potent and selective histamine H3 receptor antagonist
Timothy A Esbenshade, Kaitlin E Browman, Thomas R Miller, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 22, 2008
Characterization of a cannabinoid CB2 receptor-selective agonist, A-836339 [2,2,3,3-tetramethyl-cyclopropanecarboxylic acid [3-(2-methoxy-ethyl)-4,5-dimethyl-3H-thiazol-(2Z)-ylidene]-amide], using in vitro pharmacological assays, in vivo pain models, and pharmacological magnetic resonance imaging
Betty B Yao, Gin Hsieh, Anthony V Daza, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 21, 2004
Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: II. Neurophysiological characterization and broad preclinical efficacy in cognition and schizophrenia of a potent and selective histamine H3 receptor antagonist
Gerard B Fox, Timothy A Esbenshade, Jia Bao Pan, et al.
Biochemical Pharmacology
|
March 21, 2007
Novel heterocyclic-substituted benzofuran histamine H3 receptor antagonists: in vitro properties, drug-likeness, and behavioral activity
Marlon Cowart, Gregory A Gfesser, Kaitlin E Browman, et al.
Epilepsia
|
September 9, 2005
Preclinical profiling and safety studies of ABT-769: a compound with potential for broad-spectrum antiepileptic activity
William J Giardina, Michael J Dart, Richard R Harris, et al.
CNS Neuroscience & Therapeutics
|
May 17, 2008
Preclinical characterization of A-582941: a novel alpha7 neuronal nicotinic receptor agonist with broad spectrum cognition-enhancing properties
Karin R Tietje, David J Anderson, R Scott Bitner, et al.
Page
of 7